• 

  A Glimpse of the Future from the Alzheimer’s Association International Conference
• 

  Next-Generation Alzheimer’s Drugs Show Mixed Results at AAIC
• 

  FDA Approves At-Home Injectable Leqembi for Early Alzheimer’s
• 

  THC/CBD Shows Promise for Treating Agitation in Late-Stage Alzheimer’s
• 

  Alzheimer’s Treatments 2026: Here’s Every FDA-Approved Therapy and What Comes Next
• 

  Can Gene Therapy Change the Course of Alzheimer’s?
• 

  Is China’s ‘Alzheimer’s Surgery’ Too Good to Be True?
• 

  FDA Approves New Drug for Alzheimer’s Agitation
• 

  Review Questions Impact of Anti-Amyloid Drugs
• 

  New Drug for Rare Childhood Dementia Wins FDA Accelerated Approval
• 

  Targeting the ApoE4 Gene to Treat Alzheimer’s
• 

  An Unexpected Alzheimer’s Candidate: Lithium
• 

  Company Pulls Alzheimer’s Drug Application After EU Rejection
• 

  Low-Dose Lithium Trial Sets the Stage for Future Alzheimer’s Studies
• 

  Could Targeting Gum Disease Bacteria Slow Alzheimer’s?

12Next